First quarter Adjusted EBITDA of
$395 million
Safely completed scheduled turnaround at Burnaby Refinery on
time and on budget
CALGARY,
AB, May 3, 2023 /PRNewswire/ - Parkland
Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI),
today announced its financial and operating results for the three
months ended March 31, 2023.
Q1 2023 Highlights
- Adjusted EBITDA attributable to Parkland ("Adjusted
EBITDA"1) of $395 million,
consistent with the first quarter of 2022 with contributions from
acquisitions and organic growth offsetting the impact of the
scheduled turnaround completed at the Burnaby Refinery in the first
quarter of 2023 (the "2023 Turnaround").
- Net earnings attributable to Parkland ("net earnings") of
$77 million ($0.44 per share, basic) up 40 percent from the
first quarter of 2022, and Adjusted earnings attributable to
Parkland ("Adjusted earnings"2) of $114 million ($0.65
per share, basic) down 16 percent from the first quarter of
2022.
- Cash generated from operating activities of $314 million ($1.79
per share, basic3) up $362
million from the first quarter of 2022.
- Leverage ratio4 of 3.3x (3.4x in Q4 2022) and
liquidity available3 of $1.5
billion.
- Continued to expand our ON the RUN convenience brand to
approximately 670 locations and grew our JOURNIETM
rewards loyalty program to 4.5 million members.
- Subsequent to the quarter, announced a partnership between
JOURNIETM rewards loyalty program and Aeroplan and
opened the first ON the RUN standalone retail location in
British Columbia.
"The Company's disciplined focus on delivering shareholder value
continues to guide us and we are on track for a successful year.
Our performance this quarter demonstrates our ability to execute on
our strategy, capture synergies and deliver organic growth
throughout our retail and commercial businesses," said Bob Espey, President and Chief Executive
Officer. "I am confident Parkland will deliver its $2 billion Adjusted EBITDA ambition by 2025
without additional acquisitions, while reducing leverage and
improving shareholder returns."
Q1 2023 Segment Highlights
- Canada delivered Adjusted
EBITDA of $167 million, down 13
percent from Q1 2022 ($191 million).
Unseasonably warm weather lowered commercial volumes, partially
offset by 2022 acquisitions and organic growth. Fuel margins
declined year-over-year due to favourable retail market conditions
in Q1 2022. Food and Company C-Store Same Store Sales Growth
("SSSG") (excluding cigarettes)2 was 6.8 percent (1.7
percent in Q1 2022).
- International delivered Adjusted EBITDA of $183 million, up 123 percent, from Q1 2022
($82 million). Performance was
largely driven by the consolidation of the remaining 25% of Sol and
additional volumes captured largely in the contracted commercial
and retail business, organic growth initiatives and synergies.
- USA delivered Adjusted EBITDA
of $21 million, down 55 percent, from
Q1 2022 ($47 million). Results were
negatively impacted by the compliance obligations accounted for in
the current period of $17 million,
commodity price fluctuations in 2022 and severe winter weather
across certain markets.
- Refining delivered Adjusted EBITDA of $38 million, down 57 percent, from Q1 2022
($89 million) reflecting the
scheduled 2023 Turnaround. Composite utilization5 was
33.9 percent. These impacts were partially offset by increased
sales of imported product and efficient management of pipeline
capacity.
Parkland's sustainability accomplishments are described in the
Q1 2023 MD&A (as defined below). Notably, Parkland's total
recordable injury frequency rate ("TRIF"5) on a
trailing-twelve-months basis was 0.97 in Q1 2023, a decrease of 18
percent compared to the Q1 2022 TRIF of 1.19.
__________________________
|
1 Total of
segments measure. See "Total of Segments Measures" section of this
news release.
|
2 Non-GAAP financial measure or
non-GAAP financial ratio. See "Non-GAAP Financial Measures and
Ratios" section of this news release.
|
3 Supplementary financial measure.
See "Supplementary Financial Measures" section of this news
release.
|
4 Capital
management measure. See "Capital Management Measures" section of
this news release.
|
5 Non-financial measure. See
"Non-Financial Measures" section of this news release.
|
Consolidated Financial Overview
($ millions, unless
otherwise noted)
|
Three months ended
March 31,
|
Financial
Summary
|
2023
|
2022
|
Sales and operating
revenue
|
8,156
|
7,606
|
Adjusted EBITDA
attributable to Parkland ("Adjusted
EBITDA")(1)
|
395
|
387
|
Canada
|
167
|
191
|
International
|
183
|
82
|
USA
|
21
|
47
|
Refining
|
38
|
89
|
Corporate
|
(14)
|
(22)
|
Net earnings (loss)
attributable to Parkland
|
77
|
55
|
Net earnings (loss) per
share – basic ($ per share)
|
0.44
|
0.36
|
Net earnings (loss) per
share – diluted ($ per share)
|
0.43
|
0.35
|
Trailing-twelve-month
("TTM") Cash generated from (used in) operating
activities(2)
|
1,688
|
592
|
Cash generated from
(used in) operating activities
|
314
|
(48)
|
TTM Cash generated from
(used in) operating activities per share(2)
|
10.23
|
3.88
|
(1) Total of segments
measure. See "Total of Segments Measures" section of this news
release.
|
(2) Supplementary
financial measure. See "Supplementary Financial Measures" section
of this news release.
|
Q1 2023 Conference Call and Webcast Details
Parkland will host a webcast and conference call on Thursday, May 4, 2023 at 6:30 am MDT (8:30 am
EDT) to discuss the results. To listen to the live webcast
and watch the presentation, please use the following link:
https://app.webinar.net/nog8aEnNBqP
Analysts and investors interested in participating in the
question-and-answer session of the conference call may do so by
calling 1-888-390-0546 (toll-free) (Conference ID: 79037941).
International participants may call 1-800-389-0704 (toll-free)
(Conference ID: 79037941).
Please connect and log in approximately 10 minutes before the
beginning of the call. The webcast will be available for replay two
hours after the conference call ends at the link above. It will
remain available for one year and will also be posted to
www.parkland.ca.
MD&A and Consolidated Financial Statements
The management's discussion and analysis for the three months
ended March 31, 2023 (the "Q1 2023
MD&A") and consolidated financial statements for the three
months ended March 31, 2023 (the "Q1
2023 Consolidated Financial Statements") provide a detailed
explanation of Parkland's operating results. An English version of
these documents will be available online at
www.parkland.ca and SEDAR after the results are released by
newswire under Parkland's profile at www.sedar.com. The French
versions of the Q1 2023 MD&A and the Q1 2023 Consolidated
Financial Statements will be posted to www.parkland.ca and
SEDAR as soon as they become available.
About Parkland Corporation
Parkland is an international fuel distributor and retailer with
operations in twenty-five countries. Our purpose is to Power
Journeys and Energize Communities, and every day, we provide over
one million customers with the essential fuels, convenience items
and quality foods on which they depend.
With approximately 4,000 retail and commercial locations across
Canada, the United States, and the Caribbean region, we have developed supply,
distribution, and trading capabilities to accelerate growth and
business performance. In addition to meeting our customers' needs
for essential fuels, we provide a range of choices to help them
lower their environmental impact. These include carbon and
renewables trading, solar power, renewables manufacturing and
ultrafast Electric Vehicle charging.
Our proven business model is centered around organic growth, our
supply advantage, driven by scale and our integrated refinery and
supply infrastructure, acquiring prudently, and integrating
successfully. Our strategy is focused on developing our existing
business in resilient markets, growing our food, convenience, and
renewable energy businesses, and helping customers to decarbonize.
Our business is underpinned by our people, and our values; safety,
integrity, community, and respect, which are deeply embedded across
our organization.
Forward-Looking Statements
Certain statements contained in this news release constitute
forward-looking information and statements (collectively,
"forward-looking statements"). When used in this news release the
words "expect", "will", "could", "would", "believe", "continue",
"pursue" and similar expressions are intended to identify
forward-looking statements. In particular, this news release
contains forward-looking statements with respect to, among other
things: Parkland's business model, objectives and strategies,
including its ambition to reach $2
billion of Adjusted EBITDA by 2025 without further
acquisitions, reduce leverage and improve shareholder returns.
These statements involve known and unknown risks, uncertainties
and other factors that may cause actual results or events to differ
materially from those anticipated in such forward-looking
statements. No assurance can be given that these expectations will
prove to be correct and such forward-looking statements included in
this news release should not be unduly relied upon. These
forward-looking statements speak only as of the date of this news
release. Parkland does not undertake any obligations to publicly
update or revise any forward-looking statements except as required
by securities law. Actual results could differ materially from
those anticipated in these forward-looking statements as a result
of numerous risks, assumptions and uncertainties including, but not
limited to: general economic, market and business conditions,
including the duration and impact of the COVID-19 pandemic and the
Russia-Ukraine conflict; micro and macroeconomic
trends and conditions, including increases in interest rates,
inflation and commodity prices; Parkland's ability to execute its
business objectives, projects and strategies, including the
completion, financing and timing thereof, realizing the benefits
therefrom and meeting our targets and commitments relating thereto;
Parkland's management systems and programs and risk management
strategy; the competitive environment of our industry; retail
pricing, margins and refining crack spreads; availability and
pricing of petroleum product supply; volatility of crude oil and
refined product prices; ability of suppliers to meet commitments;
actions by governmental authorities and other regulators including
but not limited to increases in taxes or restricted access to
markets; environmental impact; changes in environmental and
regulatory laws, including the ability to obtain or maintain
required permits; and other factors, many of which are beyond the
control of Parkland. Assumptions related to Parkland's ambition to
reach $2 billion of Adjusted EBITDA
by 2025 include an estimated $150
million of synergies from completed acquisitions and cost
efficiencies and $180 million of
organic growth compared to the 2022 financial results. See also the
risks and uncertainties described in "Cautionary Statement
Regarding Forward-Looking Information" and "Risk Factors" included
in Parkland's most recent Annual Information Form, and in
"Forward-Looking Information" and "Risk Factors" included in the Q1
2023 MD&A, each filed on SEDAR and available on the Parkland
website at www.parkland.ca. The forward-looking statements
contained in this news release are expressly qualified by this
cautionary statement.
Non-Financial Measures
Parkland uses a number of non-financial measures, including
composite utilization and total recordable injury frequency rate,
in measuring the success of our strategic objectives and to set
variable compensation targets for employees. These non-financial
measures are not accounting measures, do not have comparable
International Financial Reporting Standards ("IFRS") measures, and
may not be comparable to similar measures presented by other
issuers, as other issuers may calculate these metrics differently.
See Section 16 of the Q1 2023
MD&A, which is incorporated by reference into this news
release, for further details on the non-financial measures used by
Parkland.
Specified Financial Measures
This news release contains total of segments measures, non-GAAP
financial measures and non-GAAP financial ratios, supplementary
financial measures and capital management measures (collectively,
"specified financial measures"). Parkland's management uses certain
specified financial measures to analyze the operating and financial
performance, leverage and liquidity of the business. These
specified financial measures do not have any standardized meaning
under IFRS and are therefore unlikely to be comparable to similar
measures presented by other companies. The specified financial
measures should not be considered in isolation or used in
substitute for measures of performance prepared in accordance with
IFRS. See Section 16 of the Q1 2023
MD&A, which is incorporated by reference into this news
release, for further details regarding specified financial measures
used by Parkland.
Non-GAAP Financial Measures and Ratios
Adjusted earnings (loss) and Adjusted earnings (loss) per share
are a non-GAAP financial measure and a non-GAAP financial ratio,
respectively, representing the underlying core operating
performance of business activities of Parkland at a consolidated
level.
Adjusted earnings (loss) and Adjusted earnings (loss) per share
represent how well Parkland's operational business is performing,
while considering depreciation and amortization, interest on leases
and long-term debt, accretion and other finance costs, and income
taxes. The Company uses these measures because it believes that
Adjusted earnings (loss) and Adjusted earnings (loss) per share are
useful for management and investors in assessing the Company's
overall performance as they exclude certain significant items that
are not reflective of the Company's underlying business
operations.
Adjusted earnings (loss) excludes costs that are not considered
representative of Parkland's underlying core operating performance
including: (i) costs related to potential and completed
acquisitions, (ii) non-core acquisition and integration employee
costs, (iii) business integration and restructuring costs,
(iv) changes in the fair value of share-based compensation
liabilities, (v) unrealized gains and losses on (a) foreign
exchange, (b) risk management assets and liabilities unless they
relate to underlying physical sales activity in current period and
(c) derivatives, (vi) realized foreign exchange gains and losses as
a result of cash pooling arrangements and refinancing activities,
(vii) realized foreign exchange gains and losses on accrued
financing costs in foreign currency and the offsetting realized
risk management gains and losses on the related foreign exchange
risk management instruments, (viii) changes in values of the Sol
put option, redemption options under Parkland's senior unsecured
notes, environmental liabilities and asset retirement obligations,
(ix) loss on inventory write-downs for which there are offsetting
associated risk management derivatives with unrealized gains, *
impairments of non-current assets, (xi) loss on modification of
long-term debt, (xii) earnings impact from hyperinflation
accounting, (xiii) certain realized gains and losses on risk
management assets and liabilities that are related to underlying
physical sales activity in another period, (xiv) gains and losses
on asset disposals, (xv) adjustment for the effect of market-based
performance conditions for equity settled share-based award
settlements, and (xvi) other adjusting items. Parkland's
Adjusted earnings (loss) and Adjusted earnings (loss) per share are
also adjusted to include Parkland's proportionate share of its
joint-venture investees' Adjusted earnings (loss). Concurrently
with Parkland entering into the Share Exchange Agreement, effective
August 4, 2022, Parkland does not allocate a portion of Adjusted
earnings (loss) to NCI and includes 100 percent of International
results as Adjusted earnings (loss).
Please see below for the reconciliation of Adjusted earnings
(loss) to net earnings (loss) and calculation of Adjusted earnings
(loss) per share.
|
Three months ended
March 31,
|
($ millions, unless
otherwise stated)
|
2023
|
2022
|
Net earnings (loss)
attributable to Parkland
|
77
|
55
|
Add: Net earnings
(loss) attributable to NCI
|
—
|
13
|
Net earnings
(loss)
|
77
|
68
|
Add:
|
|
|
Acquisition,
integration and other costs
|
27
|
13
|
(Gain) loss on foreign
exchange – unrealized
|
7
|
6
|
(Gain) loss on risk
management and other – unrealized
|
(32)
|
11
|
Other (gains) and
losses
|
21
|
72
|
Other adjusting
items(1)
|
21
|
6
|
Tax
normalization(2)
|
(7)
|
(26)
|
Adjusted earnings
(loss) including NCI
|
114
|
150
|
Less: Adjusted earnings
(loss) attributable to NCI
|
—
|
14
|
Adjusted earnings
(loss)
|
114
|
136
|
Weighted average number
of common shares (million shares)(3)
|
175
|
155
|
Weighted average number
of common shares adjusted for the effects of dilution (million
shares)(3)
|
177
|
156
|
Adjusted earnings
(loss) per share ($ per share)
|
|
|
Basic
|
0.65
|
0.88
|
Diluted
|
0.64
|
0.87
|
(1)
|
Other Adjusting Items
for the three months ended March 31, 2023 include: (i) the effect
of market-based performance conditions for equity-settled
share-based award settlements of $13 million (2022 - nil), and (ii)
the share of depreciation and income taxes for Isla joint venture
of $3 million (2022 - $4 million).
|
(2)
|
The tax normalization
adjustment was applied to net earnings (loss) adjusting items that
were considered temporary differences, such as acquisition,
integration and other costs, unrealized foreign exchange gains and
losses, unrealized gains and losses on risk management and other,
gains and losses on asset disposals, changes in fair value of
redemption options, changes in estimates of environmental
provisions, loss on inventory write-downs for which there are
offsetting associated risk management derivatives with unrealized
gains, impairments of non-current assets and debt modifications.
The tax impact was estimated using the effective tax rates
applicable to jurisdictions where the related items
occur.
|
(3)
|
Weighted average number
of common shares are calculated in accordance with Parkland's
accounting policy contained in Note 2 of the Annual Consolidated
Financial Statements.
|
Food and Company C-Store SSSG refers to the period-over-period
sales growth generated by retail food and convenience stores at the
same company sites. The effects of opening and closing stores,
temporary closures (including closures for ON the RUN / Marché
Express conversions), expansions of stores, renovations of stores,
and stores with changes in food service models in the period are
excluded to derive a comparable same-store metric. Same-store sales
growth is a metric commonly used in the retail industry that
provides meaningful information to investors in assessing the
health and strength of Parkland's brands and retail network, which
ultimately impacts financial performance. Food and Company C-Store
SSSG does not have any standardized meaning prescribed under IFRS
and is therefore unlikely to be comparable to similar measures
presented by other companies. Please see below for a reconciliation
of convenience store revenue (Food and C-Store revenue) of the
Canada segment with the Food and
Company C-Store same store sales ("SSS") and calculation of the
Food and Company C-Store SSSG.
|
Three months ended
March 31,
|
($ millions)
|
2023
|
2022
|
%(1)
|
Food and Company
C-Store revenue
|
70
|
100
|
|
Add:
|
|
|
|
Point-of-sale ("POS")
value of goods and services sold at Food and Company C-Store
operated by retailers and franchisees(2)
|
278
|
165
|
|
Less:
|
|
|
|
Rental and royalty
income from retailers, franchisees and
others(3)
|
(55)
|
(34)
|
|
Same Store revenue
adjustments(4) (excluding cigarettes)
|
(80)
|
(21)
|
|
Food and Company
C-Store same-store sales
|
213
|
210
|
1.6 %
|
Less:
|
|
|
|
Same Store revenue
adjustments(4) (cigarettes)
|
(87)
|
(92)
|
|
Food and Company
C-Store same-store sales (excluding cigarettes)
|
126
|
118
|
6.8 %
|
|
Three months ended
March 31,
|
($ millions)
|
2022
|
2021
|
%(1)
|
Food and Company
C-Store revenue
|
100
|
92
|
|
Add:
|
|
|
|
Point-of-sale ("POS")
value of goods and services sold at Food and Company C-Store
operated by retailers(2)
|
165
|
129
|
|
Less:
|
|
|
|
Rental income from
retailers and others(3)
|
(25)
|
(24)
|
|
Same Store revenue
adjustments(4)(5) (excluding cigarettes)
|
(60)
|
(7)
|
|
Food and Company
C-Store same-store sales
|
180
|
190
|
(5.5) %
|
Less:
|
|
|
|
Same Store revenue
adjustments(4)(5) (cigarettes)
|
(91)
|
(103)
|
|
Food and Company
C-Store same-store sales (excluding cigarettes)
|
89
|
87
|
1.7 %
|
(1)
|
Percentages are
calculated based on actual amounts and are impacted by
rounding.
|
(2)
|
POS values used to
calculate Food and Company C-Store SSSG are not a Parkland
financial measure and do not form part of Parkland's consolidated
financial statements.
|
(3)
|
Includes rental income
from retailers in the form of a percentage rent on Food and Company
C-Store sales, royalty, franchisee fees and excludes revenues from
automated teller machines, POS system licensing fees, and
others.
|
(4)
|
This adjustment
excludes the effects of acquisitions, opening and closing stores,
temporary closures (including closures for ON the RUN / Marché
Express conversions), expansions of stores, renovations of stores,
and stores with changes in food service models, to derive a
comparable same-store metric.
|
(5)
|
Excludes sales from
acquisitions completed within the year as these will not impact the
metric until after the completion of one year of the acquisitions
when the sales or volume generated establish the baseline for these
metrics.
|
The non-GAAP financial measures and ratios should not be
considered in isolation or used in substitute for measures of
performance prepared in accordance with IFRS. Except as otherwise
indicated, these non-GAAP measures and ratios are calculated and
disclosed on a consistent basis from period to period. See section
16 of the Q1 2023 MD&A, which is incorporated by reference into
this news release, for further details regarding Parkland's
non-GAAP financial measures and ratios.
Supplementary Financial Measures
Parkland uses a number of supplementary financial measures,
including cash generated from (used in) operating activities per
share and liquidity available to evaluate the success of our
strategic objectives and to set variable compensation targets for
employees. These measures may not be comparable to similar measures
presented by other issuers, as other issuers may calculate these
metrics differently. See Section 16
of the Q1 2023 MD&A, which is incorporated by reference into
this news release, for further details regarding supplementary
financial measures used by Parkland.
Capital Management Measures
Parkland's primary capital management measure is the Leverage
Ratio, which is used internally by key management personnel to
monitor Parkland's overall financial strength, capital structure
flexibility, and ability to service debt and meet current and
future commitments. The Leverage Ratio is calculated as a ratio of
Leverage Debt to Leverage EBITDA (each as defined in the Q1 2023
Consolidated Financial Statements) and does not have any
standardized meaning prescribed under IFRS. It is therefore
unlikely to be comparable to similar measures presented by other
companies. See Section 16 of the Q1
2023 MD&A, which is incorporated by reference into this news
release, for further details regarding capital management measures
used by Parkland.
Total of Segments Measures
Adjusted EBITDA is a total of segments measure used by the chief
operating decision maker to make decisions about resource
allocation to the segment and to assess its performance. In
accordance with IFRS, adjustments and eliminations made in
preparing an entity's financial statements and allocations of
revenue, expenses, and gains or losses shall be included in
determining reported segment profit or loss only if they are
included in the measure of the segment's profit or loss that is
used by the chief operating decision maker. As such, Parkland's
Adjusted EBITDA is unlikely to be comparable to similarly named
measures presented by other issuers, who may calculate these
measures differently. Parkland views Adjusted EBITDA as the key
measure for the underlying core operating performance of business
segment activities at an operational level. Adjusted EBITDA is used
by management to set targets for Parkland (including annual
guidance and variable compensation targets) and is used to
determine Parkland's ability to service debt, finance capital
expenditures and provide for dividend payments to shareholders.
See Section 16 of the Q1 2023
MD&A, which is incorporated by reference into this news
release, for further details regarding total of segments measures
used by Parkland. Refer to the table below for the reconciliation
of Adjusted EBITDA to net earnings (loss) for the three months
ended March 31, 2023 and
March 31, 2022.
|
Three months ended
March 31,
|
($ millions)
|
2023
|
2022
|
Adjusted EBITDA
attributable to Parkland ("Adjusted EBITDA")
|
395
|
387
|
Add: Attributable to
NCI
|
—
|
27
|
Adjusted EBITDA
including NCI
|
395
|
414
|
Less:
|
|
|
Acquisition,
integration and other costs
|
27
|
13
|
Depreciation and
amortization
|
190
|
155
|
Finance
costs
|
104
|
70
|
(Gain) loss on foreign
exchange – unrealized
|
7
|
6
|
(Gain) loss on risk
management and other – unrealized
|
(32)
|
11
|
Other (gains) and
losses(1)
|
21
|
72
|
Other adjusting
items(2)
|
21
|
6
|
Income tax expense
(recovery)
|
(20)
|
13
|
Net earnings
(loss)
|
77
|
68
|
Net earnings (loss)
attributable to Parkland
|
77
|
55
|
Net earnings (loss)
attributable to NCI
|
—
|
13
|
(1)
|
Other (gains) and
losses for the three months ended March 31, 2023 include the
following: (i) nil non-cash valuation gain (2022 - $4 million loss)
due to the change in redemption value of Sol Put Option; (ii) $9
million non-cash valuation gain (2022 - $86 million loss) due to
the change in fair value of redemption options; and (iii) $30
million loss (2022 - $18 million gain) in Other items including $23
million (2022 - nil) in write-off of certain assets related to
renewable diesel complex. Refer to Note 12 of the Interim
Condensed Consolidated Financial Statements.
|
(2)
|
Other Adjusting Items
for the three months ended March 31, 2023 mainly include: (i) the
effect of market-based performance conditions for equity-settled
share-based award settlements of $13 million (2022 - nil), and (ii)
the share of depreciation and income taxes for Isla joint venture
of $3 million (2022 - $4 million).
|
Parkland uses Adjusted gross margin as a measure of segment
profit (loss) to analyze the performance of sale and purchase
transactions and performance on margin. Adjusted gross margin
excludes the effects of significant items of income and expenditure
that are not considered representative of Parkland's underlying
core margin performance and may have an impact on the quality of
margins, such as (i) unrealized gains and losses on (a) foreign
exchange, (b) risk management and other unless underlying physical
sales activity has occurred, (ii) loss on inventory write-downs for
which there are offsetting associated risk management and other
with unrealized gains, (iii) certain realized gains and losses on
risk management assets and liabilities that are related to
underlying physical sales activity in another period, and (iv)
other adjusting items. Refer to the table below for the
reconciliation of Adjusted gross margn.
|
Three months ended
March 31,
|
($ millions)
|
2023
|
2022
|
Sales and operating
revenue
|
8,156
|
7,606
|
Cost of
purchases
|
(7,265)
|
(6,563)
|
Gain (loss) on risk
management and other - realized
|
39
|
(183)
|
Gain (loss) on foreign
exchange - realized
|
6
|
8
|
Other adjusting items
to Adjusted gross margin
|
2
|
—
|
Adjusted gross
margin
|
938
|
868
|
|
|
|
Fuel and petroleum
product adjusted gross margin
|
766
|
734
|
Convenience and other
non-fuel adjusted gross margin
|
172
|
134
|
Adjusted gross
margin
|
938
|
868
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/parkland-reports-2023-first-quarter-results-301815271.html
SOURCE Parkland Corporation